Recursion Pharmaceuticals, Inc. - RXRX

Include option trades

Include indirect trades

Latest data: 6/18/2026 10:01:40 PM

EDGAR CIK

1 Month 3 Month 6 Month 1 Year 2 Years

Buy Breakdown

Total $0

No buy transactions for this time period.

Sell Breakdown

Total $4,844,914

Monthly Totals

Transaction	Filed	Name	Type	Shares @ Price	Value	Balance change		Ownership
06/05/2026 10b5-1	06/05/2026	Khan Najat CEO and President CEO Director	Sell	-23,588 @ $3.58	($84,459.19)	2,175,796	(-1.07%)	Direct
06/03/2026 10b5-1	06/04/2026	Bumpus Namandje Director	Sell	-4,386 @ $3.54	($15,526.44)	43,171	(-9.22%)	Direct
06/02/2026 10b5-1	06/04/2026	Borgeson Blake Director	Sell	-30,000 @ $3.68	($110,400.00)	6,169,863	(-0.48%)	Direct
05/05/2026 10b5-1	05/07/2026	Borgeson Blake Director	Sell	-30,000 @ $3.52	($105,600.00)	6,199,863	(-0.48%)	Direct
04/07/2026 10b5-1	04/08/2026	Borgeson Blake Director	Sell	-30,000 @ $3.10	($93,000.00)	6,229,863	(-0.48%)	Direct
03/17/2026 10b5-1	03/18/2026	Taylor Ben R Chief Financial Officer CFO	Sell	-7,956 @ $3.39	($26,970.84)	1,180,318	(-0.67%)	Direct
03/09/2026 10b5-1	03/11/2026	Khan Najat CEO and President CEO Director	Sell	-28,298 @ $3.35	($94,659.64)	2,262,085	(-1.24%)	Direct
03/03/2026	03/04/2026	Borgeson Blake Director	Sell	-170,000 @ $3.46	($588,200.00)	6,259,863	(-2.64%)	Direct
02/18/2026 10b5-1	02/19/2026	Taylor Ben R Chief Financial Officer CFO	Sell	-13,426 @ $3.08	($41,352.08)	1,195,349	(-1.11%)	Direct
02/03/2026 10b5-1	02/06/2026	Borgeson Blake Director	Sell	-220,000 @ $4.20	($924,000.00)	6,429,863	(-3.31%)	Direct
01/06/2026 10b5-1	01/08/2026	Borgeson Blake Director	Sell	-220,000 @ $4.36	($959,200.00)	6,649,863	(-3.20%)	Direct
12/29/2025 10b5-1	12/30/2025	Taylor Ben R Chief Financial Officer CFO	Sell	-21,383 @ $4.18	($89,380.94)	761,550	(-2.73%)	Direct
12/22/2025 10b5-1	12/29/2025	Khan Najat Chief R&D Commercial Officer Officer Director	Sell	-124,403 @ $4.41	($548,592.35)	611,135	(-16.91%)	Direct
12/02/2025 10b5-1	12/04/2025	Borgeson Blake Director	Sell	-220,000 @ $4.37	($961,400.00)	6,869,863	(-3.10%)	Direct
08/18/2025	08/19/2025	Khan Najat Chief R&D Commercial Officer Officer Director	Sell	-36,599 @ $5.52	($202,172.88)	668,197	(-5.19%)	Direct